Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29)
Kyung Im Kim(Korea University), Jung Mi Oh(Seoul National University), Jae Hyun Kim(Seoul National University), Inho Kim(Seoul National University Hospital), Jin Seok Kim(University of Ulsan), Sung‐Soo Yoon(Seoul National University Hospital), Seonyang Park(Seoul National University), Eun Hee Ji, Jun Ho Jang(Samsung Medical Center), Ji‐Hyun Kwon(Chungbuk National University Hospital), Galina Velikova(University of Leeds)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
|Leukemia|2017|356
Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier
|Journal of Controlled Release|1998|337